BiotechTube
Home/ProVascTec/Dr. Holger Müller, CFA
DH

Dr. Holger Müller, CFA

CEO & Co-Founder

ProVascTec

Therapeutic Areas

CardiovascularPeripheral Artery Disease

ProVascTec Pipeline

DrugIndicationPhase
Stem Cell Therapy for CLICritical Limb Ischemia (Below-the-Knee)Pre-clinical

Leadership Team at ProVascTec

PD
Prof. Dr. Noel Caplice
CSO & Co-Founder
View full ProVascTec profile